Literature DB >> 20488527

Tuberculosis and HIV: time for an intensified response.

Tedros Adhanom Ghebreyesus1, Michel Kazatchkine, Michel Sidibé, Hiroki Nakatani.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20488527     DOI： 10.1016/S0140-6736(10)60595-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Linkage to HIV care and antiretroviral therapy in Cape Town, South Africa.

Authors:  Katharina Kranzer; Jennifer Zeinecker; Philip Ginsberg; Catherine Orrell; Nosindiso N Kalawe; Stephen D Lawn; Linda-Gail Bekker; Robin Wood
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

2.  Integrating intensified case finding of tuberculosis into HIV care: an evaluation from rural Swaziland.

Authors:  Susan Elden; Timothy Lawes; Søren Kudsk-Iversen; Joris Vandelanotte; Sabelo Nkawanyana; William Welfare; John Walley; John Wright
Journal:  BMC Health Serv Res       Date:  2011-05-23       Impact factor: 2.655

3.  Successes and Challenges in an Integrated Tuberculosis/HIV Clinic in a Rural, Resource-Limited Setting: Experiences from Kericho, Kenya.

Authors:  Douglas N Shaffer; Eunice T Obiero; Josphat B Bett; Ignatius N Kiptoo; Jonah K Maswai; Fredrick K Sawe; E Jane Carter
Journal:  AIDS Res Treat       Date:  2012-02-16

4.  Outcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008.

Authors:  Mauro Sanchez; Patricia Bartholomay; Denise Arakaki-Sanchez; Donald Enarson; Karen Bissell; Draurio Barreira; Anthony Harries; Afrânio Kritski
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

5.  An Overview of Tuberculosis-Designated Hospitals in China, 2009-2015: A Longitudinal Analysis of National Survey Data.

Authors:  Yuhong Liu; Yu Pang; Jian Du; Wei Shu; Yan Ma; Jingtao Gao; Lijie Zhang; Shaofa Xu; Liang Li
Journal:  Biomed Res Int       Date:  2019-08-20       Impact factor: 3.411

6.  Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice.

Authors:  Qi Xin; Hongxia Niu; Zhi Li; Guoping Zhang; Lina Hu; Bingxiang Wang; Jingjing Li; Hongjuan Yu; Wanbo Liu; Yue Wang; Zejiao Da; Ruiying Li; Qiaoyang Xian; Yong Wang; Ying Zhang; Tao Jing; Xingming Ma; Bingdong Zhu
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

7.  Levofloxacin-proliposomes: opportunities for use in lung tuberculosis.

Authors:  Wipaporn Rojanarat; Titpawan Nakpheng; Ekawat Thawithong; Niracha Yanyium; Teerapol Srichana
Journal:  Pharmaceutics       Date:  2012-08-13       Impact factor: 6.321

8.  A New Rabbit-Skin Model to Evaluate Protective Efficacy of Tuberculosis Vaccines.

Authors:  Huiyu Chen; Xun Liu; Xingming Ma; Qian Wang; Guang Yang; Hongxia Niu; Shuaixiang Li; Bingzheng He; Shanshan He; Arthur M Dannenberg; Bingdong Zhu; Ying Zhang
Journal:  Front Microbiol       Date:  2017-05-17       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.